Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 3, 1997, Pages 233-238

  Sugimachi, Keizo ^a   Maehara, Yoshihiko ^a   Ogawa, Michio ^b   Kakegawa, Teruo ^c   Tomita, Masao ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Postoperative chemotherapy; Prognosis; Recurrence; UFT

Indexed keywords

KRESTIN; MITOMYCIN C; UFT;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; PROTEOGLYCANS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; URACIL;

EID: 0030952183     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050652     Document Type: Article

References (28)

1. Arima S, Ohsato K, Hisatsugu T, Shimura H (1994) Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer. Eur J Surg 160: 227
2. Chou F-F, Sheen-Chen S-M, Liu P-P, Chen F-C (1994) Adjuvant chemotherapy for resectable gastric cancer: a preliminary report. J Surg Oncol 57: 239
3. Dixon WJ (ed) (1988) BMDP statistical software. University of California Press. Berkeley
4. Fujii S, Ikenaka K, Fukushima M, Shirasaka T (1978) Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 69: 763
5. Gamelin EC, Danquechin-Dorval E, Dumesnil YF, Maillart PJ, Goudier MJ, Burtin PC, Delva RG, Lortholary AH, Gesta PH, Larra FG (1996) Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer 77: 441
6. Hallissey MT, Dunn JA, Ward LC, Allum WH (1994) The Second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343: 1309
7. Hanaue H, Kurosawa T, Kitano Y, Miyakawa S, Nemoto A, Yamamoto H, Asagoe T, Takada T, Yasuda H, Shikata J (1987) Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil. Cancer 59: 1571
8. Ikenaka K., Shirasaka T, Kitano S, Fujii S (1979) Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann 70: 353
9. Japanese Research Society for Gastric Cancer (1981) The General Rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Clinical classification. Jpn J Surg 11: 127. Part II. Histological classification of gastric cancer. Jpn J Surg 11: 140
10. Japanese Research Society for Gastric Cancer (1981) The General Rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Clinical classification. Jpn J Surg 11: 127. Part II. Histological classification of gastric cancer. Jpn J Surg 11: 140
11. Konishi T, Miyama T, Sakamoto S, Hirata T, Mafune K, Hiraishi M, Idezuki Y (1992) Activities of thymidylate synthetase and thymidine kinase in gastric cancer. Surg Oncol 1: 215
12. Konishi T, Hiraishi M, Mafune K, Miyama T, Hirata T, Mori K, Nishida H, Idezuki Y (1994) Therapeutic efficacy and toxicity of sequential methotrexate and 5-fluorouracil in gastric cancer. Anticancer Res 14: 1277
13. Lise M, Nitti D, Marchet A, Fornasiero A (1991) Adjuvant treatment for gastric cancer. Anticancer Drugs 2: 433
14. Lise M, Nitti D, Marchet A, Sahmoud T, Buyse M, Duez N, Fiorentino M, Dos Santos JG, Labianca R, Rougier P, Giginoux M (1995) Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. J Clin Oncol 13: 2757
15. Maehara Y, Anai H, Kusumoto H, Sugimachi K (1987) Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol 13: 203
16. Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sugimachi K (1988) UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Chemotherapy 34: 484
17. Maehara Y, Watanabe A, Kakeji Y, Babe H, Kohnoe S, Sugimachi K (1990) Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma. Am J Surg 160: 242
18. Maehara Y, Moriguchi S, Sakaguchi Y, Emi Y, Kohnoe S, Tsujitani S, Sugimachi K (1990) Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer. J Surg Oncol 45: 169
19. Maehara Y, Sugimachi K, Akagi M, Kakegawa T, Shimazu H, Tomita M (1992) Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer. Br J Cancer 65: 413
20. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 343: 1122
21. Oken MM, Davis TE, Creech RH, McFadden ET, Tormey DC, Carbone PP, Horton J (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649
22. Ota K, Taguchi T, Kimura K (1988) Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22: 333
23. Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV, Markowitz AB, Abbruzzese JL, Bready B, Levin B (1994) Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12: 2296
24. Sakamoto S, Kawachi Y, Konishi T (1993) Pathological features and pyrimidine micleotide synthesis in human gastric carcinomas. Anticancer Res 13: 879
25. Tseng CC, Nio Y, Shiraishi T, Tubone M, Morimoto H, Kawabata K, Masai Y, Tun T, Fukumoto M, Tobe T (1991) Comparative study on various combination chemotherapies against human gastric cancer xenograft lines of well- and poorly-differentiated adenocarcinomas transplanted in nude mice. Anticancer Drugs 2: 457
26. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K (1984) Krestin (PSK). Cancer Treat Rev11: 131
27. Wada H, Hitomi S, Teramatsu T (1994) Postoperative non-small cell lung cancer: a prospective rundomized trial of cisplatin (P)-vindesine (VDS)-UFT vs UFT alone vs control. Proc Am Soc Clin Oncol 13: 328
28. WHO Handbook for Reporting Results of Cancer Treatment (1979) WHO Offset Publication no. 48, World Health Organisation, Geneva